A pilot, early angiographic patency study using a direct thrombin inhibitor as adjunctive therapy to streptokinase in acute myocardial infarction.
Rosa María Lidón(Montreal Heart Institute), Julie Lévesque(Université du Québec à Trois-Rivières), Jacques Lespérance(Montreal Heart Institute), R Bonan(Montreal Heart Institute), Pierre Théroux(Montreal Heart Institute), Burt Adelman(Unknown), Damien Duval(Montreal Heart Institute)
Cited by 99
Related Papers
Pathophysiology of Coronary Artery Disease
|Circulation|2005|2k
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
|New England Journal of Medicine|2015|2k
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
|New England Journal of Medicine|2012|941
Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina
|New England Journal of Medicine|1995|496